Two Sigma Securities »

Monopar Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $34k 47k 0.73
2023-09-30 $15k 25k 0.62

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Monopar Therapeutics

Millennium Management
Geode Capital Management
Two Sigma Securities
Vanguard Group
Gerber
Virtu Financial
Rappaport Reiches Capital Management
Tower Research Capital
FMR
Goss Wealth Management
UBS Group
Wells Fargo & Company
Bank of America Corporation
Federation des caisses Desjardins du Quebec

View all funds holding Monopar Therapeutics